Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Apr
17
UCB Announces FINTEPLA® (fenfluramine) Oral Solution Is Now Descheduled and Is No Longer Listed as a Controlled Substance
Apr
14
Recognizing UCB’s Rising Stars: Brittany Blair and Lauren Drowley Recognized by the Healthcare Businesswomen’s Association
Apr
13
UCB’s Commitment to Understanding Sudden Unexpected Death in Epilepsy (SUDEP)
Mar
17
Exploring the future of dermatology at AAD 2023
Mar
16
You Speak, We Listen: How Community Voices Drive Our Work in HS
Mar
15
Building a Community of Trust in Epilepsy & Rare Syndromes
Feb
17
Patient-First, Patient-Focused: Our Purpose and Promise
Jan
20
Employee Spotlight: Ian Crassweller – Leading and Evolving Through Change
Jan
18
Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis